Home › Funds › Decheng Capital LLC › ACRS

Decheng Capital LLC position in ACRS

ACLARIS THERAPEUTICS INC · Health Care

Decheng Capital LLC reported holding 4,041,736 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$21.3M, representing 3.10% of its reported portfolio and ranking #3 among its reported holdings. Decheng Capital LLC has disclosed ACRS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)4.04M sh
Reported value held$21.26M
Portfolio Weight3.10%
First reportedQ4 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Decheng Capital LLC's ACRS position evolved

Decheng Capital LLC first disclosed a stake in ACRS in Q4 2024 at 2,266,667 shares (US$5.6M). The position peaked in Q2 2026 at 4,041,736 shares, worth US$21.4M. Across 8 filings, Decheng Capital LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 4,041,736 shares valued at US$21.3M. Notable position changes include a 78% increase in Q1 2025 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.27M $5.62M New
Q1 2025 4.04M $6.18M Add
Q2 2025 4.04M $5.74M Hold
Q3 2025 4.04M $7.68M Hold
Q4 2025 4.04M $12.17M Hold
Q1 2026 4.04M $15.16M Hold
Q2 2026 4.04M $21.38M Hold
Q3 2026 4.04M $21.26M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACRS and 13F data

ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACRS

All ACRS fund holders →

FAQ

How long has Decheng Capital LLC held ACRS?

Decheng Capital LLC has disclosed ACRS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Decheng Capital LLC's current position in ACRS?

As of Q3 2026, Decheng Capital LLC holds 4.04M shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $21.26M, representing 3.10% of its reported portfolio and ranking #3.

Has Decheng Capital LLC been buying or selling ACRS?

In the latest 13F filing (Q3 2026), Decheng Capital LLC held unchanged its position in ACRS. The position peaked in Q2 2026 at 4.04M shares.

Which other funds hold ACRS?

Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.